MedTrace Logo

Early Revascularization in Stable Ischemic Heart Disease Using P.E.T. Imaging

NCT05018247 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2023-10-18

No results posted yet for this study

Summary

To compare the impact of revascularization and Optimal Medical Treatment (OMT) on the extent of severely reduced coronary flow capacity in stable ischemic heart disease.

Conditions

  • Ischemic Heart Disease

Interventions

PROCEDURE

Revascularization by Coronary Artery Bypass Graft or Percutaneous Coronary Intervention

Urgent revascularization via CABG or PCI combined with Optimal Medical Treatment

Sponsors & Collaborators

  • The University of Texas Health Science Center, Houston

    lead OTHER

Principal Investigators

  • K. Lance Gould, MD · UT Health Science Center Houston

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-04
Primary Completion
2022-05-19
Completion
2022-05-19

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05018247 on ClinicalTrials.gov